Please join us for this free online scientific webinar on the 9th June 2022 at 13:00 BST,  where you will learn how Olink’s unique proteomic technology which is offered at Leeds Immunogenomic Core Facility in the LIGHT Laboratories is empowering scientists to explore the dynamic proteome within precision medicine research. Demonstrating that the Olink protein library covers all major biological pathways which cover numerous research fields across cancer, cardiovascular, neurological, immunological and inflammatory disorders. 

Themes to be included will be: 

• Application of the Olink platform in clinical research to explore disease mechanisms. 
• Examine treatment responses. 
• Determine clinically relevant biomarkers.

We are greatly honoured to have Dr. James Peters speaking who has worked closely with Leeds Immunogenomic Core Facility to apply the Olink technology within his own research. Dr. Peters will present how his group used a multiomic approach with plasma proteomics, RNA-sequencing and flow cytometry of immune cells, to identify distinct transcriptomic and proteomic molecular temporal profiles of COVID-19 disease severity. The plasma proteome was found to be a superior indicator of clinical severity than the PBMC transcriptome.

Others include Anne-Li Lind, PhD and Neuroscience Specialist from Olink’s Scientific Affairs Team. Anne-Li will present case studies and published findings on longitudinal examination of treatment responses in the context of oncology research. As well as the use of Olink’s Proximity Extension Assay (PEA) Technology in plasma and cerebrospinal fluid for defining protein signatures for disease classification and disease progression in dementia research.